Showing 1531-1540 of 2050 results for "".
- Revance Brings Mepivacaine-Based Fillers to US Markethttps://modernaesthetics.com/news/revance-brings-mepivacaine-based-fillers-to-us-market/2483155/Revance has announced the US launch of the Teoxane RHA® Collection with Mepivacaine, marking a significant innovation in dermal filler formulations. The update reflects a shift in anesthetic agents used in hyaluronic acid fillers, with mepivacaine replacing lidocaine as the primary ane
- Oral GLP-1 Hits Phase 3 Trial Targets; Regulatory Submissions Cominghttps://modernaesthetics.com/news/oral-glp-1-hits-phase-3-trial-targets-regulatory-submissions-coming/2483149/Eli Lilly and Company announced positive topline results from its Phase 3 ATTAIN-2 trial, showing that its investigational oral GLP-1 receptor agonist, orforglipron, achieved significant weight loss and improved cardiometabolic outcomes in adults with obesity or overweight status and type 2 diabe
- Device Manufacturer’s Initiative Offers Treatments to Support Firefighters’ Healthhttps://modernaesthetics.com/news/device-manufacturers-initiative-offers-treatments-to-support-firefighters-health/2483123/BTL Industries has launched a nationwide initiative aimed at addressing the mental and physical health challenges faced by firefighters, particularly those serving in high-risk wildfire regions. The program is framed under BTL’s Heros Deserve Healing campaign, which calls on clinicians an
- Study: Aesthetic Surgeries Rise Among GLP-1 RA Patientshttps://modernaesthetics.com/news/study-aesthetic-surgeries-rise-among-glp-1-ra-patients/2476139/Aesthetic surgery among patients with previous glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is increasing compared with postbariatric surgery patients, according to new research published in the Aesthet
- AMI Pharm Advances AYP-101 to Phase 3 Testing for Noninflammatory Fat Reductionhttps://modernaesthetics.com/news/ami-pharm-advances-ayp-101-to-phase-3-testing-for-noninflammatory-fat-reduction/2476093/AMI Pharm has initiated a pivotal Phase 3 clinical trial of AYP-101, an investigational injectable for the treatment of submental fat. The study will evaluate the efficacy and safety of the agent, which is designed to reduce localized fat with fewer inflammatory side effects than current therapie
- SkinCeuticals Introduces A.G.E. Interrupter Ultra Serum to Address Sagging Skinhttps://modernaesthetics.com/news/skinceuticals-introduces-age-interrupter-ultra-serum-to-address-sagging-skin/2476036/SkinCeuticals announced the launch of its A.G.E. Interrupter Ultra Serum, a new addition to its A.G.E. line designed to target skin laxity. Sagging skin, often heightened by factors such as rapid weight loss, has become a growing concern among patients seeking dermatologic care. This serum offers
- Survey: Dermatologists Remain Top Influencers in Cosmetic Procedure Decisionshttps://modernaesthetics.com/news/survey-dermatologists-remain-top-influencers-in-cosmetic-procedure-decisions/2475930/Dermatologists continue to lead as the primary influencers in patients’ decisions regarding cosmetic procedures, according to the American Society for Dermatologic Surgery’s (ASDS) 2025 Consumer Survey on Cosmetic Dermatologic Procedures. The annual survey, which collected responses from more tha
- Report: GLP-1s Dethrone Skincare Shifting Medical Aesthetic Spendhttps://modernaesthetics.com/news/report-glp-1s-dethrone-skincare-shifting-medical-aesthetic-spend/2475902/Weight-loss medications continue to impact the medical aesthetics industry. GLP-1s surpassed skincare as the top consumer spend category, according to a new report from Guidepoint Qsight. Guidepoint Qsight found patients are focusing on the overall wellness journey, prioritizing bundling
- BOTOX Cosmetic Selects Entrepreneurs for 2025 Confidence Projecthttps://modernaesthetics.com/news/botox-cosmetic-selects-entrepreneurs-for-2025-confidence-project/2475812/Allergan Aesthetics, an AbbVie company, announced the 2025 class of participants in The Confidence Project: Empowering Women Entrepreneurs, a national program led by BOTOX Cosmetic (onabotulinumtoxinA). The initiative is designed to address the confidence gap among women in business and
- SkinSpirit Makes Donation to Kerr County Flood Relief Fundhttps://modernaesthetics.com/news/skinspirit-makes-donation-to-kerr-county-flood-relief-fund/2475718/SkinSpirit has donated to the Kerr County Flood Relief Fund as part of their philanthropic arm, SS Gives. “With our large number of Texas-based clinics, we are proud to donate to the Kerr County